ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,702, issued on Dec. 30, was assigned to AstraZeneca AB (Sodertalje, Sweden).
"Inducible modification of a cell genome" was invented by Marcello Maresca (Sodertalje, Sweden), Mohammad Bohlooly-Yeganeh (Sodertalje, Sweden), Himjyot Jaiswal (Sodertalje, Sweden), Lorenz M. Mayr (Sodertalje, Sweden) and Xiufeng Xu (Sodertalje, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed, in some embodiments, to compositions and methods for inducible modification of a cell genome."
The patent was filed on Feb. 3, 2021, under Application No. 17/166,823.
*For further information, including images, charts and tables, please visi...